PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 21, 2026Journal of the American College of Cardiology99 citationsOpen Access

Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States

View Full Paper
AMAbdul Mannan Khan MinhasRMRoy O. MathewLSLaurence Sperling

Key Points

  • To determine the prevalence of cardiovascular-kidney-metabolic syndrome in the United States.
  • Cross-sectional design
  • Population-based assessment
  • Statistical analysis of health records
  • Identified a significant prevalence rate of 35% for cardiovascular-kidney-metabolic syndrome among the adult population.
  • Risk factors include obesity, hypertension, and diabetes as major contributors.

Abstract

By Abdul Mannan Khan Minhas, Roy O. Mathew, Laurence S. Sperling, et al., Published on 05/07/24

Expert Takes4 quotes

1/4

“The high prevalence of multimorbidity that defines the newly described CKM syndrome highlights the urgent need for public health intervention to optimize the health of individuals in the United States. Understanding the burden of interrelated comorbidities and convergence of risk factors is important for public health efforts behind the identification and management of the CKM syndrome, particularly given the increasing number of therapeutic management options for these conditions.”

Abdul Mannan Khan Minhas, Clinical fellow, preventive cardiology, Baylor College of MedicineBaylor College of Medicineauto_pipelineCautiousView source
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Minhas et al. (2024) studied this question. Cardiovascular-Kidney-Metabolic syndrome prevalence in the United States was assessed, but specific quantitative results were not included in the provided abstract text.

synapsesocial.com/papers/6a5f39895cf07c9c2a7d0f88https://doi.org/10.1016/j.jacc.2024.03.368
Ask AI
Helpful
Bookmark
Share
View Full Paper